Gheuens Sarah bought AGIO
October 22, 2026 · Form 4 insider transaction
Gheuens Sarah bought 500 shares of Agios Pharmaceuticals, Inc. at $25.01 per share, a transaction worth $12.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
500
Price
$25.01
Total value
$12.5K
InsiderGheuens Sarah
Role—
SecurityCommon stock
Transaction codeM: Option exercise
Transaction dateOctober 22, 2026
Filing dateOctober 23, 2026
Shares owned after55,145
OwnershipDirect
10b5-1 planNo
AmendedNo